- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba's MR Interface Receives FDA Clearance
Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.
Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.
M-Power will be available for use on Toshiba’s Vantage Atlas, Vantage Titan 1.5 and Titan 3T MR systems with the ability to upgrade already-installed systems.
M-Power reduces the steps to start a procedure, and the interface is designed to enhance and personalize work flow. The Atlas Compass software automates coil selection and turns on the proper coil elements needed for an exam. Finally, mVOX, a volume imaging acquisition sequence available for neuro and orthopedic applications, allows the acquisition of all 3D imaging to be acquired at the same time, according to the company.
“M-Power makes Toshiba’s sophisticated suite of MR software easy to learn and use, allowing technologists of every skill level to access the system’s full range of functionality,” Stuart Clarkson, director, MR Business Unit, Toshiba, said in the company release. “MR technologists are now able to design their own protocols and easily access mTools for greater convenience and productivity.”
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
